ENDRA Life Sciences Inc. (NDRA) Shareholders’ equity 2016–2020
ENDRA Life Sciences Inc. (NDRA) shareholders’ equity at each fiscal year-end, per SEC filings.
$7.2MFY2020 · since FY2016: -$893,767 → $7.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | $7.2M | +50.6% |
| FY2019 | $4.8M | -23.8% |
| FY2018 | $6.2M | +18.4% |
| FY2017 | $5.3M | +690.3% |
| FY2016 | -$893,767 | — |
Source: SEC XBRL filings · For reference only · Not investment advice